These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent Developments in PET and SPECT Radiotracers as Radiopharmaceuticals for Hypoxia Tumors. Nguyen AT; Kim HK Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514026 [TBL] [Abstract][Full Text] [Related]
3. Khosravifarsani M; Ait-Mohand S; Paquette B; Sanche L; Guérin B Front Med (Lausanne); 2022; 9():975213. PubMed ID: 36226156 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of Diaza-Crown Ether-Backboned chelator containing hydroxamate groups for Zr-89 chelation chemistry. Zhang S; Wang H; Ren S; Chen Y; Liu D; Li M; Sagastume E; Chong HS Bioorg Med Chem Lett; 2022 Sep; 72():128847. PubMed ID: 35700955 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Cytotoxicity Assessment of [ Khosravifarsani M; Ait-Mohand S; Paquette B; Sanche L; Guérin B Nanomaterials (Basel); 2021 Aug; 11(9):. PubMed ID: 34578470 [TBL] [Abstract][Full Text] [Related]
8. Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator. Alnahwi AH; Ait-Mohand S; Dumulon-Perreault V; Dory YL; Guérin B ACS Omega; 2020 May; 5(19):10731-10739. PubMed ID: 32455192 [TBL] [Abstract][Full Text] [Related]
9. New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging. Gai Y; Sun L; Hui W; Ouyang Q; Anderson CJ; Xiang G; Ma X; Zeng D Inorg Chem; 2016 Jul; 55(14):6892-901. PubMed ID: 27347690 [TBL] [Abstract][Full Text] [Related]
10. [Development of new peptide-based chelating agents for site-specific radiolabeling with 64Cu]. Miyamoto T; Kamino S; Odani A; Hiromura M; Enomoto S Yakugaku Zasshi; 2014; 134(7):797-800. PubMed ID: 24989468 [TBL] [Abstract][Full Text] [Related]
11. Labeling biomolecules with radiorhenium: a review of the bifunctional chelators. Liu G; Hnatowich DJ Anticancer Agents Med Chem; 2007 May; 7(3):367-77. PubMed ID: 17504162 [TBL] [Abstract][Full Text] [Related]
12. Development of bifunctional chelates bearing hydroxamate arms for highly efficient (64)Cu radiolabeling. Ait-Mohand S; Denis C; Tremblay G; Paquette M; Guérin B Org Lett; 2014 Sep; 16(17):4512-5. PubMed ID: 25133292 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals. Ferreira CL; Yapp DT; Lamsa E; Gleave M; Bensimon C; Jurek P; Kiefer GE Nucl Med Biol; 2008 Nov; 35(8):875-82. PubMed ID: 19026949 [TBL] [Abstract][Full Text] [Related]
14. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides. Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958 [TBL] [Abstract][Full Text] [Related]
15. Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for Seibold U; Wängler B; Wängler C ChemMedChem; 2017 Sep; 12(18):1555-1571. PubMed ID: 28715615 [TBL] [Abstract][Full Text] [Related]